A detailed history of Credit Agricole S A transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Agricole S A holds 21,772 shares of REGN stock, worth $15.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
21,772
Previous 9,418 131.17%
Holding current value
$15.5 Million
Previous $9.9 Million 131.23%
% of portfolio
0.1%
Previous 0.05%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1024.09 - $1201.76 $12.7 Million - $14.8 Million
12,354 Added 131.17%
21,772 $22.9 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $657,984 - $798,036
745 Added 8.59%
9,418 $9.9 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $3.15 Million - $3.47 Million
3,489 Added 67.3%
8,673 $8.35 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $999,207 - $1.14 Million
1,289 Added 33.09%
5,184 $4.55 Million
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $179,344 - $218,691
259 Added 7.12%
3,895 $3.21 Million
Q2 2023

Jul 31, 2023

BUY
$700.03 - $830.35 $112,004 - $132,856
160 Added 4.6%
3,636 $2.61 Million
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $138,819 - $168,701
204 Added 6.23%
3,476 $2.86 Million
Q4 2022

Feb 13, 2023

SELL
$705.89 - $766.39 $1.49 Million - $1.62 Million
-2,113 Reduced 39.24%
3,272 $2.36 Million
Q3 2022

Nov 10, 2022

BUY
$573.97 - $724.32 $1.56 Million - $1.97 Million
2,714 Added 101.61%
5,385 $3.71 Million
Q2 2022

Aug 08, 2022

BUY
$548.35 - $738.84 $1.33 Million - $1.79 Million
2,418 Added 955.73%
2,671 $1.58 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $148,780 - $174,607
-250 Reduced 49.7%
253 $177,000
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $57,403 - $68,096
-100 Reduced 16.58%
503 $304,000
Q2 2021

Aug 10, 2021

SELL
$472.8 - $558.54 $39,242 - $46,358
-83 Reduced 12.1%
603 $337,000
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $134,019 - $164,460
300 Added 77.72%
686 $324,000
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $6.04 Million - $7.68 Million
-12,633 Reduced 97.04%
386 $187,000
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $327,939 - $396,242
602 Added 4.85%
13,019 $7.29 Million
Q2 2020

Aug 13, 2020

BUY
$493.32 - $643.92 $1.6 Million - $2.09 Million
3,250 Added 35.45%
12,417 $7.74 Million
Q1 2020

May 14, 2020

BUY
$336.18 - $494.43 $3.03 Million - $4.46 Million
9,019 Added 6093.92%
9,167 $4.48 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $14,380 - $19,911
48 Added 48.0%
148 $46,000
Q2 2018

Aug 10, 2018

BUY
$284.6 - $344.99 $28,460 - $34,499
100 New
100 $34,000
Q4 2017

Feb 13, 2018

SELL
$358.63 - $469.95 $17 Million - $22.2 Million
-47,332 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $9.32 Million - $10.9 Million
21,614 Added 84.04%
47,332 $21.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
25,718
25,718 $12.6 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.